Endothelial activation and infiltration of monocyte macrophages are essential prerequisites for fibrous cap formation, which comprises proliferation and migration of smooth muscle cells and net matrix deposition. Macrophage foam cells and endothelium act as a source of growth factors and chemoattractants for smooth muscle cells. However, growth factors alone do not stimulate smooth muscle cell proliferation or migration. This requires, in addition, the remodelling of the extracellular matrix, at least partly mediated by metalloproteinases. In particular, loss of basement membrane components and contact with the interstitial matrix appears to be required to release a brake on proliferation and migration exerted by the basement membrane. Unless there is a change in the phenotype of macrophages in advanced lesions, it is not clear why fibrous cap destruction rather than formation should take place in macrophage-rich shoulder regions of plaques. Impaired cap formation caused by smooth muscle senescence, mummification and propensity to apoptosis may be as important as increased cap destruction in promoting plaque rupture.
Introduction
focus for an enormous body of molecular and cellular biology literature, itself the subject of authoritative reviews The characteristic feature of the advanced atherosand regular updates [6] [7] [8] [9] [10] [11] . The purpose of this article is clerotic plaque is irregular thickening of the arterial intima to focus critically on the extent to which these processes by inflammatory cells, extracellular lipid (atheroma) and might determine plaque stability. fibrous tissue (sclerosis) (Fig. 1) . A large part of the lesions comprise seemingly inert and acellular fibrous tissue but there is often a distinct and highly cellular 2. Evolution of the fibrous cap fibrous cap (Fig. 1) . In eccentric lesions, such as the one shown in Fig. 1 , there is also a leucocyte-rich 'shoulder 2.1. Experimental approaches region' at the limit between the plaque and the relatively normal tissue. The fibrous cap undoubtedly contributes
The primary tool for investigating the evolution of something to luminal encroachment but its importance has atherosclerosis in humans has been the careful observation recently been emphasised as a strong determinant of the of necropsy material from individuals of widely different likelihood of plaque rupture, which leads in turn to ages [12, 13] . The reasonable premise is that plaque age is thrombosis followed either by occlusion or episodic plaque somehow related to biological age. Alternatively, in fewer expansion [1] [2] [3] [4] . Fibrous cap formation arises from the studies, the degree of stenosis has been taken as an indirect migration and proliferation of vascular smooth muscle indicator of plaque age [14] . From observations of patients cells and from matrix deposition [5] . The mechanisms of different ages, fibrous cap formation appears to be a underlying these processes have rightly therefore been the relatively late event in atherosclerosis, occurring after and, by implication, as an evolution from macrophage-rich fatty profile. Expression of endothelial leukocyte adhesion molecules and production of macrophage chemoattractants, including monocyte chemotactic peptide-1 (MCP-1), from smooth muscle cells [33] may orchestrate this motion. Oxidation of low-density lipoprotein (LDL) that has entered the vessel wall has a central role in stimulating adhesion molecule and MCP-1 expression [34] . Subsequently, there appears to be migration of smooth muscle from the media into the intima (Fig. 2a) . This is clearly visible at early time points in both mice and rabbits (Fig.  3) , where there is no pre-existing intimal population. In man and other animals where there is already an intimal smooth muscle cell population, it is possible that plaque smooth muscle cells derive solely from these cells [8] .
Interestingly, smooth muscle cell proliferation has been observed in diffuse intimal thickenings [35] , which implies marker of macrophages (brown stain). fc5fibrous cap, lc5lipid core, that this population could expand to provide plaque smooth sr5shoulder region. The scale bar shows 100 mm.
muscle cells. However, the frequent observation of large disruptions of the internal elastic lamina and wasting of the streak lesions [15] . This sequence of events is consistent media at the base of human atherosclerotic plaques (see, with studies of cholesterol fed rabbits [16, 17] and primates for example, reference [36] ) strongly suggests that at least [18] [19] [20] [21] and with observations on genetically hypersome plaque smooth muscle cells are recruited from the lipidaemic rabbits [22, 23] and mice [24] . The animals used media. to model atherogenesis have a shorter life span than man Data from human plaques of type III, before formation and economic considerations preclude observations over of a distinct fibrous cap [15] , apoE-deficient mice on a the greater than 20 years that human lesions require to Western-type diet [24] and cholesterol-fed rabbit aortas evolve into clinically apparent disease. The hope is that the (e.g. Fig. 3 ) suggest that migration of smooth muscle cells evolution of lesions in these models mirrors that in man then occurs through foam cell-rich areas, as illustrated except in being conveniently accelerated. An additional schematically in Fig. 2b . Production of platelet-derived difference between man and most of the animal models, growth factor (PDGF) B chains from macrophages, which except swine [25] and primates [20] , is the presence of a has been observed at all stages of atherogenesis in both significant population of mesenchymal cells, presumed to human and experimental models [5, 37, 38] , is probably be vascular smooth muscle cells, in the normal arterial relevant in recruiting smooth muscle cells to the intima. intima. This population and, hence, neointimal thickness is Heparin-binding epidermal growth-factor-like growth facexpanding throughout life, even in the absence of atherotor (HB-EGF) from macrophages also plays a role in sclerosis. Studies by Smirnov's group (Orekhov et al. [26] ) smooth muscle cell (SMC) migration [39] . However, the in which the intimal cell population in the aorta was expected outcome would be a mosaic of macrophages and counted showed that human aortic atherosclerotic plaques smooth muscle cells, as seen in Fig. 3 . Additional mechacontained approximately twice as many smooth muscle nisms must explain the formation of a distinct fibrous cap. cells as found in the neighboring normal areas. PathologiSorting of cells through cell surface cadherins may contribcal studies demonstrate that atherosclerotic plaques deute [40] , since smooth muscle cells, but not macrophages, velop within preexisting areas of neointimal thickening in express N-cadherin [41] . Homotypic binding between man [27] , an observation confirmed in an experimental arrays of N-cadherin monomers could then lead to strong swine model [25] .
smooth muscle cell-to-cell interactions that would exclude macrophages. N-cadherin is also expressed together with 2.2. Determinants of fibrous cap morphogenesis VE-cadherin on endothelial cells [41] and this favours endothelial cell smooth muscle cell contacts [42] . Plaque morphology is generated by the organised moMigration of smooth muscle cells along an endothelial tion of the constituent cell types, namely vascular smooth to medial gradient of chemoattractant is another likely muscle cells and various blood leucocytes. As shown in mechanism underlying cap formation (Fig. 2c) . Activated  Fig. 2a , the initial and most well established event is the endothelium [43] produces PDGFBB [44] and insulin-like movement of blood monocytes across the endothelium and growth factor-1 (IGF-1) [9] . The endothelium is essential their transformation to tissue macrophages in the subenfor neointimal migration of smooth muscle cells in organ dothelial matrix [28] [29] [30] [31] [32] . Entry of further monocytes and cultures of pig aorta [45] . The presence of endothelium lymphocytes leads to the fatty streak, which is regarded as [46] and PDGF [47] are also both necessary for neointimal a stable lesion, due perhaps to its low haemodynamic migration of smooth muscle cells in human saphenous veins. A further possibility is PDGFAB production from situation in ApoE mice [53, 55] . Cholesterol-fed, geplatelets, where there is evidence for platelet adhesion to netically normal rabbits seem to have more superficially sub-endothelium in the late stage of atherogenesis (Fig. 2c) superimposed lesions (Fig. 3) . Similarly, in human cor- [21, 48] . An additional possibility is fibrin degradation onary vein grafts, lesions often show little penetration into products, which are known to arise from plasma fibrinogen the previously thickened neointima, which leads to the and to adopt a subendothelial to medial concentration invidious, friable toothpaste-like lesions that are characgradient in human plaques [49, 50] . Perhaps these factors teristic of failed grafts [56] . In the later stages of fibrous act in concert.
plaque morphogenesis (Fig. 2c) , there may be migration of Apart from the medial to intimal migration of smooth smooth muscle cells away from sites of cell proliferation. muscle cells described in Fig. 2 , there is also circumferenAt the same time, penetration of fresh monocytes must be tial motion, leading to expansion of the media. This preferentially directed to the perimeter of the fibrous cap to accounts for the well accepted compensatory increase in explain the existence of leucocyte-rich shoulder regions. arterial diameter with atherosclerosis [51] , and for the Mast cells are detected preferentially in the shoulder initial increase in lumen diameter in vein grafts [52] .
regions of later stage atheromas [57] . These might contrib-A further event may be penetration of macrophages into ute to the fresh entry of macrophages and lymphocytes as the media (Fig. 2c) , for which there is good evidence in well as to T lymphocytes growth by producing tumour mouse [53] and Watanabe rabbit models [54] . In human necrosis factor a (TNFa) [58] . TNFa is a mediator of coronary arteries and, particularly in aneurysmal dilatation endothelium-leukocyte adhesion molecule-1 induction of the abdominal aorta, there is wasting and inflammatory [59] and an enhancer of T lymphocyte growth [60] . infiltration of the media, which may be analogous to the Macrophages and endothelial-derived chemoattractants in [67] . The epithelioid phenotype has not yet been identified in other species, including man. However, bovine pulmonary arteries contain four distinct cell phenotypes, at least two of which are clearly smooth muscle cells [68] . Observations of cell shape in alcoholicalkaline etched preparations of human aorta also identify four populations (elongated, elongated with side process, irregular and stellate). The proportion of the stellate phenotype, possibly equivalent to the senescent phenotype in culture, increases in atherosclerotic tissue [12, 26] or in vitro in response to transforming growth factor-b (TGF-b) [69] . Some recent observations may cast doubt on whether the atherosclerotic neointimal mesenchymal cells derive from differentiated smooth muscle cells at all. Many lesional neointimal cells stain poorly for typical markers of smooth muscle cells, including desmin and smooth muscle cell a-actin or myosin [70] [71] [72] . Some authors suggest a fibroblast origin for these cells [73] , while others suggest, more cautiously, an indeterminate origin [66, 68, 74] . Adventitial fibroblasts expressing smooth muscle cell a-actin have been identified migrating into the thickened neoin- [75] and in restenotic lesions after angioplasty [73] .
1% cholesterol diet for eight weeks [149] . Sections were stained for (A) Development of more selective immunocytochemical macrophages (RAM-11 antibody) and (B) vascular smooth muscle cells (a-smooth muscle actin) [149] . Arrows denote the presence of smooth markers that differentiate between smooth muscle cells and plaque caps may be derived from myofibroblasts. these shoulder regions presumably attract further smooth 2.4. The role of cell proliferation muscle cells either from the subjacent media or from the edges of the existing fibrous cap.
Simplistically, the data from Smirnov's studies, alluded to above, imply that a single population doubling in 20 2.3. What is the source of the neointimal connective years, equivalent to a proliferative index of approximately tissue?
0.01%, is sufficient to account for the increase in smooth muscle cell numbers in atherosclerotic plaques. The large A pervasive concept, advanced by Chamley-Campbell amounts of acellular connective tissue in plaques [14] may and Campbell [61] , is that normal contractile smooth imply the net loss of a further one or two cell doublings muscle cells can undergo reversible modulation into a through necrosis or apoptosis. Even so, the very low rates synthetic phenotype that is capable of both proliferation of cell proliferation that have been observed in plaques and enhanced matrix synthesis [62] . The response to (0-1% PCNA proliferation index) [35] are entirely convascular injury, such as balloon dilatation, clearly demsistent with the extent of intimal enlargement. These very onstrates that smooth muscle cells, as a population, possess low rates cannot be used therefore to discount the importhe ability to change phenotype [63, 64] . However, cell tance of proliferation as a component of atherogenesis. proliferation can occur before and, hence, independently of Smooth muscle cells are capable of doubling within 48 h phenotypic modulation [65, 66] . What remains uncertain is in tissue culture or immediately after balloon injury [65] . whether or not the sluggish proliferation in atherosclerotic
The most interesting question is therefore not so much why plaques results from phenotypic modulation of typical smooth muscle cells proliferate in atherosclerosis but how contractile smooth muscle cells. Data from several species their proliferation is so effectively suppressed in the suggests the possibility that the smooth muscle cells in normal vessel wall. A parameter more difficult to define is the number of ation either by acting as a nutrient [90] or a specific population doublings undergone by individual intimal mitogen [89, 91] . Oxidised lipoproteins generally cause a cells. Benditt and Benditt [76] were the first to observe that decrease in smooth muscle cell expansion rates but through lesional smooth muscle cells appear in many cases to have promoting apoptosis [91] . derived by clonal expansion of a small number of cells (or Criterion 2, that the factor and its receptors are present perhaps just one). Although not strictly proven, more in plaques at sufficient levels, has been met by fewer modern polymerase chain reaction (PCR)-based methods agents. One problem is that atherogenesis is both slow and [77] have largely confirmed the early work. At the same episodic and, hence, the factor may only be present time, lesion smooth muscle cells display properties of transiently or patchily. The concentration of PDGF A and transformed cells; their DNA transforms cultured fibro-B chains is increased in atherosclerotic tissue [5, 92, 93] , blasts that produce tumours in nude mice [78, 79] . Furtheralthough recent data demonstrated more PDGFA in normal more, plaque smooth muscle cells, like many transformed arteries than in plaques [94] . PDGFB chain protein has cells, show greater susceptibility to apoptosis [80] . type I receptor or through other factors [88] . Acidic and basic FGF are both present in normal and plaque smooth We previously proposed objective criteria, which are muscle cells and endothelium, although mainly sequestered updated and generalised in Table 1 , to evaluate the role of in cells or bound to the extracellular matrix [98, 99] . Hence, individual factors in aspects of atherogenesis [82] . Growth their availability at FGF receptors, other than as a result of factors for isolated human smooth muscle cells can be injury and cell death, is uncertain. Thrombin activity is categorised according to the structure of their receptors.
increased in neointima and thrombin receptors are over-PDGF, basic and acidic fibroblast growth factors (bFGF, expressed in human atherosclerotic plaques [100] [101] [102] . aFGF), IGF-1 and epidermal growth factor (EGF) all have
With the possible exception of endothelin-1 [103] , no receptors with intrinsic tyrosine kinase activity [9, 83] ; growth factor has so far met criterion 3, that an inhibitor angiotensin II, endothelin, 5-hydroxytryptamine and should prevent atherosclerosis. In the balloon-injured rat thrombin have serpentine G-protein-coupled receptors carotid artery, anti-PDGF antibodies inhibit migration of [82, 84, 85] , TGF-b has receptors with intrinsic serine / smooth muscle cells into the intima [104] while anti-bFGF threonine kinase activity [86] and interleukin-1 (IL-1) and antibodies inhibit the early proliferative response but do TNF-a have receptors that couple indirectly to serine / not reduce final intimal thickness [105] . A combination of threonine kinases [87] . All of these agents fit criterion 1, anti-PDGF and anti-bFGF antibodies greatly inhibits having been shown to promote smooth muscle cell prolifneointima formation [106] . Antibodies to TGF-b demoneration (see [7, 82] for reviews) either directly, or indirectly strate inhibitory activity against neointima formation in the by upregulating production of another growth factor or its same rat model [107] . Angiotensin-converting enzyme receptor. TGF-b has biphasic stimulatory and inhibitory inhibitors or angiotensin receptor-1 blockers and endoeffects on proliferation, mediated respectively by type I thelin receptor antagonists also partly inhibit neointima and II receptors [86, 88] . Given their importance in formation [108, 109] . Antithrombin agents also have inhibatherogenesis, the role of normal and oxidised lipoproteins itory effects on neointima formation [110] . in regulating smooth muscle cell proliferation has been From these studies, multiple growth factors appear to act extensively studied (see reference [89] ). Several normal together to stimulate neointima formation in balloon-inlipoprotein fractions stimulate smooth muscle cell proliferjured arteries by cooperative and, in cases, synergistic The mitogenic action of growth factors on smooth muscle cells is dramatically modified by their microenvironment within the vessel wall. This is shown clearly in organ culture experiments of rabbit and pig aorta and of human saphenous veins (see Fig. 4 ). Exposure to serum, which is mitogenic for the same vesicular smooth muscle cells (VSMCs) when isolated, either fails entirely to stimulate VSMC proliferation [111] or does so selectively in the subendothelial space (Fig. 4a, Fig. 4c ) [45, 46] . Proliferation in the media occurs only when this is injured (Fig. 4c) [111, 112] . These observations have counterparts in the balloon-injured rat carotid model where medial proliferation and the extent of neointima thickening depends not primarily on the extent of endothelial injury and, hence, exposure to platelet-derived mitogens but on the degree of medial injury [113] . One possible explanation for these phenomena is that multiple growth factors (e.g. PDGF plus bFGF) need to be simultaneously released by a variety of stimuli [105] , or additional factors (e.g. proteases) are needed to achieve access of growth factors to sulphate proteoglycans, many of which (e.g. syndecans, perlecan) are prominent components of the basement membrane that normally surrounds smooth muscle cells.
provides a 'brake' on proliferation of smooth muscle cells Heparin and, hence, presumably heparan sulphates act [11, 83, 115, 125] . Important support for this hypothesis has directly against proliferation by inhibiting the binding of come from Ross's group, who showed that defined exthe activator protein-1 (c-fos / c-jun) transcription factor to tracellular matrix components can prevent smooth muscle its binding sites in DNA [118] . This mechanism probably cells from passing through the cell cycle by upregulating 27 accounts also for the inhibitory effects of heparin on the p cyclin-dependent kinase inhibitor [126] . Furthersecretion of extracellular proteases including tissue plasmore, we proposed that extracellular proteolysis is the minogen activator (t-PA) and matrix metalloproteinases rate-limiting step in catabolism of all basement membrane (MMPs) [118] [119] [120] [121] . Work by Hedin et al. [122, 123] and components and is, hence, the regulated step in relieving Thyberg and Hedin [124] also shows that the basement the inhibitory constraints on proliferation [83] . The basemembrane component, laminin, inhibits while the interstiment membrane-degrading metalloproteinase, MMP-2, is tial matrix component, fibronectin, promotes phenotypic produced constitutively by smooth muscle cells [115, 127] modulation of smooth muscle cells. Based on such eviand is activated either by membrane-type metalloproteindence, we have developed a detailed hypothesis, as illusases [128] , thrombin [129] or reactive oxygen species trated in Fig. 5a , proposing that the basement membrane [130] . A second basement membrane-degrading metallo- events in the vascular response to injury [132] [133] [134] . Experiments in the human organ culture model demonstrated a spatial and temporal correlation between the expression of MMP-9 and medial cell proliferation in response to injury [135] . High concentrations of synthetic MMP inhibitors have been shown to inhibit proliferation of smooth muscle cells, particularly when proliferation is measured within the intact tissue in vitro [115] or at early time points after vascular injury in vivo [136] . On the other hand, other studies with synthetic inhibitors [137] or gene transfer of TIMP-1 in vivo [138] or by adenovirus-mediated delivery to human saphenous vein [139] showed no effect on proliferation. Hence, the role of basement membrane-degrading MMPs in regulating smooth muscle cell proliferation is uncertain. Heparanases [140, 141] and other classes of proteases, for example plasmin, cathepsins [142] or the more recently described disintegrin and metalloproteinase-containing proteins (ADAMs) [143] , might also have a role in regulating basement membrane integrity and cell proliferation.
In the context of atherosclerosis, there is strong evidence for the upregulation of interstitial stromelysin (MMP-3), collagenase (MMP-1), metalloelastase (MMP-12) and MMP-9 expression in human atherosclerotic plaques, in the cholesterol-fed rabbit and in genetically modified mice (criterion 2) [144] [145] [146] [147] [148] [149] [150] . Activity of these proteases, in particular MMP-2, is also increased [146, 149] . Increased expression has been correlated with morphological and mechanical determinants of plaque rupture [144, 145, 147, 148] . Indeed, a strong case has been made that macrophage-derived MMPs are a primary cause of plaque rupture [144, 145, 147, 148] . However, in the rabbit and mouse models, increased MMP expression and activity occurs early in the development of lesions [53, 146, 149] , As with proliferation, directed smooth muscle migration including monomeric and polymerised types I and II collagen and requires the combined action of chemoattractants and fibronectin. These also bind to integrin, including, importantly, a b and hypothesis', or whether signalling events actively suppress it neointima formation in human saphenous vein organ movement, 'the brake hypothesis' (Fig. 5) .
cultures by a selective effect on cell migration.
Migration is frequently measured with recently dis-
In vivo experiments in balloon-injured rat carotid arpersed cells crossing a microporous membrane (Boyden teries also confirm the importance of growth factors chamber assay) so as to minimise the effects of matrix working together with extracellular proteases in SMC interactions. Alternatively, reconstituted basement or intermigration. Expression of t-PA and u-PA increases after stitial matrix can be coated onto membranes in the same balloon injury [166] and tranexamic acid, an inhibitor of assay system so that chemotaxis and invasion can be plasminogen activation, decreases rat SMC migration in measured together. When migration is studied from exthis model [167] . Increased t-PA activity is partly mediated plants, in a complex organ culture or in an animal model, by PDGF [168] . Overexpression of plasminogen activator direct effects on chemotaxis and on matrix remodelling inhibitor-1 (PAI-1) results in suppression of arterial occur together, as they do physiologically. Not surprisingneointimal formation in PAI-1-deficient mice [169] . In the ly, more regulatory interactions emerge the more complex case of MMPs, both synthetic inhibitors [136, 137] and the experimental model. seeding of cells transfected with TIMP-1 [138] inhibit Using the Boyden chamber assay, some, but not all, migration of SMCs and either delay [136, 137] or inhibit smooth muscle mitogens have been shown to possess [138] neointima formation. direct chemotactic activity, which implies that the pathways for stimulating migration are overlapping but distinct 2.8. Deposition of extracellular matrix from those mediating proliferation. For example, IGF-1 is a weak activator of mitogenic pathways but potently
Contractile smooth muscle cells have low levels of total induces migration of human VSMCs [152] . One of the messenger RNA, demonstrating their limited capacity for most potent chemoattractants for smooth muscle cells is new protein synthesis. Not surprisingly, therefore, syn-PDGFBB [5,9,38,153]. PDGFBB and PDGFAA are equalthesis of extracellular matrix molecules by contractile cells ly good activators of the intracellular mitogenic pathways, is limited, although basement membrane proteoglycans, including the mitogen-activated protein kinase (MAP including syndecans and perlecan, may be an exception kinase) cascade and early response gene (e.g. c-fos) [119] . Phenotypic modulation, provoked by isolation of induction. However, PDGFAA either has no effect or cells from the tissue by collagenase, leads to a profound actually antagonises the chemotactic actions of PDGFBB alteration in both the pattern (see Fig. 5 ) and extent of chains [154, 155] . Lakatta's group has provided persuasive matrix molecule expression [170, 171] . Increased synthesis 21 21 evidence that Ca mobilization and Ca -calmodulinof hyaluronic acid is an early event that is generally activated kinase II, rather than MAP kinase, mediates associated with the production of an emergency matrix chemotaxis [156, 157] . Other mitogens, including bFGF after tissue injury [172, 173] . Basement membrane com- [158] and HB-EGF have also been shown to promote ponents, for example laminin, are downregulated [174] , migration. The effects of growth factors on migration may while synthesis of type 1 collagen, elastin and fibronectin be direct, indirect or both. For example, PDGF-BB induces is greatly increased. The components of this matrix synthesis of thrombospondin, which potentiates chemoatresemble the normal interstitial matrix, however, the traction by PDGF [159] . Moreover, PDGF and other abundance of monomeric rather than polymerised collagen mitogens, especially when combined with inflammatory may be of key importance in allowing cells to proliferate mediators, increase expression of MMPs [131, 160] . [126] . Fibronectin may polymerise into fibres, providing When invasion through reconstituted matrix is added to trackways for migration [175, 176] . Osteopontin also has a the chemotaxis assay, clear evidence for the involvement migratory effect on SMCs, which is mediated by complexof extracellular proteases, including t-PA [161] and urokining with the a b integrin [177] . Interactions of both b 5 ). Vitronectin is overexpression of tissue inhibitors of metalloproteinases-1, also known to promote migration [179, 180] . Coincident -2 or -3 inhibit migration of smooth muscle cells through with confluency, isolated smooth muscle cells begin to basement membrane [136, 138, 163, 164] . The involvement re-express basement membrane components, consistent of both classes of protease may be explained either by with their proposed role in promoting quiescence [174] . independent effects on matrix components or because Given the slow and focal nature of proliferation in plasmin is an activator of MMPs-1, -3, -7, -9 and -12.
atherosclerotic plaques, the concomitant changes in matrix Using more complex organ culture models, the importurnover would be expected to be subtle. What one tance of PDGF acting in concert with MMPs is confirmed.
observes in an overall comparison of diseased and normal Migration of SMCs out of baboon aortic depends on MMP tissue is likely to be a distant and more permanent record expression, and this is mediated by endogenous PDGF and of the immediate changes. Plaques are characterised by bFGF [165] . Both anti-PDGF antibodies [47] and adenoincreased levels of collagens I and III, and elastin, as well virus-mediated overexpression of TIMP-1 [139] [184] , where the collagen producing smooth muscle cell is true cause of plaque rupture may therefore be the exhausnot necessarily proliferating [185] . The factors likely to be tion of the reparative power of smooth muscle cells. If so, responsible for increased collagen production include then the appropriate treatment, surprisingly, might be PDGF and TGF-b [171] . This implies that PDGF and TGF locally to reinforce the stimuli for proliferation with a produced by macrophages upregulate collagen and fibrogrowth factor such as PDGF. In this sense, it may be nectin production from smooth muscle cells [186, 187] and, analogous to the observation that endothelial regrowth over hence, further promote fibrous cap formation.
a large denuded area of rat aorta remains incomplete, Many of these changes can be seen also in animal implying a limit to the regenerative capacity of the models of balloon injury [171] . Other matrix molecules endothelium. This can be overcome, nevertheless, by that are upregulated in these models include the fibrilinfusion of a mitogen, basic FGF [198] . The vigorous associated type VIII collagen [188] and the multiadhesive smooth muscle cell response to gross angioplasty injury, glycoproteins, osteopontin [189, 190] and thrombospondin metal stent implantation or deposition of a mural thrombus [159, 191] . RGD-containing peptides, which block binding further implies that the senescent phenotype can be rescued to integrins, inhibit neointimal formation after balloon by a sufficiently large stimulus. injury [192] or stent injury [193] .
Mummification

Role of the smooth muscle cell in plaque rupture
The difficulty in provoking the typical smooth muscle cell into proliferation has been emphasised throughout this 3.1. Contrasting hypotheses article, as has the importance of basement membrane as an inhibitor. It seems highly unlikely therefore that the The histological appearance of rupture-prone plaques is smooth muscle cells surrounded by multiple layers of dealt with thoroughly elsewhere in this volume. Put basement membrane frequently found in atherosclerotic simply, rupture occurs in plaques with a large lipid core, a plaques [13] could play any part in fibrous cap formation. thin cap and where there are abundant macrophages in
The reasons for the generation of this phenotype are relation to smooth muscle cells [194, 195] . It is perhaps the unclear, however, it might also be rescued by the right prevailing view that rupture results from the destruction of stimulus. an established fibrous cap, and that this is mediated by macrophages [32, 196, 197] . An alternative interpretation is that new areas of fatty streak at the edges of existing 3.1.3. Breakdown in the chemotactic gradients that fibrous plaque simply fail to generate or have not yet promote cap formation generated an adequate plaque cap. Table 2 lists six Aberrant regulation of the production of endothelial different hypotheses that might account for plaque rupture.
derived mediators is one of the earliest events in the Each has merit but gives central importance to a different preclinical phase of atherosclerosis. Increased expression component of the plaque. Below we consider these hypothof leukocyte adhesion molecules is another marker of eses from the perspective of smooth muscle cell biology.
dysfunction [43] . Late on in atherogenesis, focal loss of endothelial cells occurs [21, 48, 194] . Given these changes, 3.1.1. Smooth muscle senescence it is likely that formation of endothelium-derived PDGFBThe direct evidence that only a tiny minority (i.e. chains and other chemoattractants for smooth muscle cells clones) of cells respond to mitogenic stimuli in the slowly is impaired also. [199, 200] , nitric oxide, that elevates cGMP concentration Lipid lowering is arguably a blunderbuss approach, affect- [201] [202] [203] , interferon-g [204, 205] and TGF-b [86] all ing as it does most aspects of plaque biology. However, its antagonise the effects of smooth muscle cell mitogens. For action at the root of atherogenesis is probably the key to its example, vascular endothelial growth factor (VEGF) gene success. The search for critical molecular mediators of transfer causes NO-mediated reduction of neointima forplaque instability will rightly be the holy grail for remation after cuff-induced injury in carotid arteries [206] .
searchers in this field in the coming years. This quest will The pathways are probably diverse; downregulation of be hampered by the lack of appropriate animal models of early events, such as MAP kinase activity [207] and later plaque rupture, although transgenic animals may again events, including cyclin D1 [208] and c-myc [209, 210] provide an answer. Clinical trials will need to be large, expression, both contribute. Leucocytes are probably the protracted and expensive. Nevertheless, recent trials have most important source of all of these inhibitory agents. As established that both primary and secondary prevention of shown by Hansson and colleagues, infusion of interferon-g myocardial infarction is possible. Greater understanding of reduces intimal lesions caused by balloon injury (criterion the basic biology of fibrous cap formation and rupture 1) [206] and these are promoted in lymphocyte-deficient promises further significant advances. rats (criterion 3) [211] . Similar considerations might apply in atherogenesis. If so, the presence of leucocytes at the shoulder regions of advanced plaque might favour inhibiAcknowledgements tion rather than proliferation of smooth muscle cells. One of the most important antigens for plaque lymphocytes is
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New treatments?
[13] Stary HC. The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life.
Based on our current limited knowledge, caution is Eur Heart J 1990;11(Supple E):3-19. 
